20 articles
Large 9-year study of 2,430 women challenges assumptions about hormone replacement therapy's cardiovascular benefits.
Pfizer's landmark trial examines whether tafamidis can safely treat transthyretin amyloid cardiomyopathy, a progressive and often fatal heart condition.
Small study examined whether minimal hormone replacement could help women with chest pain and heart issues after menopause.
A 330-patient multicenter RCT tests whether thymosin ฮฑ1 can curb immune dysregulation and organ dysfunction after acute type A aortic dissection repair.
A Phase 1 trial examines if the triple-agonist GLP-1 drug retatrutide changes how the body processes the beta-blocker metoprolol.
A comprehensive review reveals tirzepatide improves blood pressure, lipids, liver fat, kidney function, and slashes 10-year cardiovascular risk by up to 23.5%.
Online cognitive behavioral therapy significantly improved disease-specific health status in heart attack survivors with cardiac anxiety.
New telerehabilitation system aims to improve exercise adherence and cardiovascular outcomes after heart attacks.
Large randomized trial tests whether deferring coronary stents during TAVI procedures is safe and effective for heart patients.
Major analysis of 38,089 older adults shows aggressive lipid-lowering therapy significantly reduces cardiovascular events.
Study compares HIIT versus standard exercise in cardiac rehabilitation patients to determine optimal fitness protocols.
A landmark 8,500-patient trial challenges 40 years of cardiology practice, finding beta blockers unnecessary after uncomplicated heart attacks.
A comprehensive GeneReviews update on Barth syndrome outlines diagnosis, new targeted therapy, and surveillance strategies for this rare X-linked disorder.
A Phase 2 trial tests once-daily oral resmetirom (MGL-3196) against placebo to reduce LDL-C in patients with inherited high cholesterol.
First-in-human study demonstrates successful transcatheter replacement of mechanical heart valves without open surgery.
Researchers tested injecting cardiac stem cells directly into heart arteries after heart attacks to promote healing and regeneration.
Completed study tested regenerative cardiac therapy in 105 heart attack patients, comparing stem cell treatment to placebo controls.
New trial shows home cardiac rehab with smartwatch monitoring equals traditional center-based programs for heart failure patients.
88-person trial tested whether adding resistance training to diet and cardio improves heart failure outcomes in elderly patients.
Major study shows tirzepatide reduces cardiovascular and kidney complications by 16% compared to dulaglutide in diabetic patients.
